Pterostilbene reduces colonic inflammation by suppressing dendritic cell activation and promoting regulatory T cell development
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pterostilbene reduces colonic inflammation by suppressing dendritic cell activation and promoting regulatory T cell development
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-23
DOI
10.1096/fj.202001502r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual Roles of PU.1 in the Expression of PD-L2: Direct Transactivation with IRF4 and Indirect Epigenetic Regulation
- (2020) Keito Inaba et al. JOURNAL OF IMMUNOLOGY
- Influence of Resveratrol on the Immune Response
- (2019) Malaguarnera Nutrients
- PU.1 plays a pivotal role in dendritic cell migration from the periphery to secondary lymphoid organs via regulating CCR7 expression
- (2019) Takuya Yashiro et al. FASEB JOURNAL
- Can molecular stratification improve the treatment of inflammatory bowel disease?
- (2019) Claire Wang et al. PHARMACOLOGICAL RESEARCH
- Pterostilbene and 4′-Methoxyresveratrol Inhibited Lipopolysaccharide-Induced Inflammatory Response in RAW264.7 Macrophages
- (2018) Yun Yao et al. MOLECULES
- The Transcription Factors PU.1 and IRF4 Determine Dendritic Cell–Specific Expression of RALDH2
- (2018) Takuya Yashiro et al. JOURNAL OF IMMUNOLOGY
- TCR Signal Strength Regulates Akt Substrate Specificity To Induce Alternate Murine Th and T Regulatory Cell Differentiation Programs
- (2017) William F. Hawse et al. JOURNAL OF IMMUNOLOGY
- Resveratrol and inflammatory bowel disease: the evidence so far
- (2017) Sandra Nunes et al. NUTRITION RESEARCH REVIEWS
- Pterostilbene Induces Cell Apoptosis and Cell Cycle Arrest in T-Cell Leukemia/Lymphoma by Suppressing the ERK1/2 Pathway
- (2017) Gaomei Chang et al. Biomed Research International
- New perspectives on mTOR inhibitors (rapamycin, rapalogs and TORKinibs) in transplantation
- (2016) Matthias Waldner et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Critical Role of Transcription Factor PU.1 in the Function of the OX40L/TNFSF4 Promoter in Dendritic Cells
- (2016) Takuya Yashiro et al. Scientific Reports
- Immunoregulatory Pathways Involved in Inflammatory Bowel Disease
- (2015) Gabriela Fonseca-Camarillo et al. INFLAMMATORY BOWEL DISEASES
- PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells
- (2015) Takuya Yashiro et al. PLoS One
- Keeping the Bowel Regular
- (2013) David J. Gibson et al. INFLAMMATORY BOWEL DISEASES
- Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins
- (2011) Takuya Yashiro et al. ATHEROSCLEROSIS
- Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells
- (2011) Nao Kitamura et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Liver Kinase B1 Is a Central Regulator of T Cell Development, Activation, and Metabolism
- (2011) Nancie J. MacIver et al. JOURNAL OF IMMUNOLOGY
- Critical role of transcription factor PU.1 in the expression of CD80 and CD86 on dendritic cells
- (2010) S. Kanada et al. BLOOD
- Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats
- (2010) Izet M. Kapetanovic et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- PKCδ-Induced PU.1 Phosphorylation Promotes Hematopoietic Stem Cell Differentiation to Dendritic Cells
- (2010) Matthias Hamdorf et al. STEM CELLS
- Involvement of PU.1 in the transcriptional regulation of TNF-α
- (2009) Tatsuo Fukai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effect of a Low Dose of Dietary Resveratrol on Colon Microbiota, Inflammation and Tissue Damage in a DSS-Induced Colitis Rat Model
- (2009) Mar Larrosa et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now